Literature DB >> 6171841

Symptom patterns in unipolar and bipolar depression correlating with monoamine metabolites in the cerebrospinal fluid: II. Suicide.

H Agren.   

Abstract

Suicidality scores from the Schedule for Affective Disorders and Schizophrenia on 21 unipolar and 12 bipolar depressives were correlated with monoamine metabolites in the cerebrospinal fluid using multiple regression analyses. The single item of Suicidal Tendencies Worst Week correlated highly significantly and negatively with 3-methoxy-4-hydroxyphenylglycol (MHPG) and only to a very slight degree with 5-hydroxyindoleacetic acid (5HIAA). Seriousness of Intent of Worst Suicide Attempt earlier in life correlated significantly and negatively with both MHPG and 5HIAA. Subjective Anger was positively and Overt Anger negatively associated with thoughts of suicide. The results support earlier reports that depressives with low 5HIAA are prone to violent suicides, but also point to the equal, if not even greater involvement of MHPG and noradrenergic neuronal systems in carrying out a wish for death.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6171841     DOI: 10.1016/0165-1781(80)90039-6

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  12 in total

1.  Brain 5-HT1 binding sites in depressed suicides.

Authors:  S C Cheetham; M R Crompton; C L Katona; R W Horton
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 2.  Suicidality and antiepileptic drugs: is there a link?

Authors:  Vladimir V Kalinin
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 3.  New directions for the treatment of depression: Targeting the photic regulation of arousal and mood (PRAM) pathway.

Authors:  Hannah E Bowrey; Morgan H James; Gary Aston-Jones
Journal:  Depress Anxiety       Date:  2017-05-10       Impact factor: 6.505

Review 4.  Genetic and biologic risk factors for suicide in depressive disorders.

Authors:  A Roy
Journal:  Psychiatr Q       Date:  1993

Review 5.  The 5-HT1A receptor in Major Depressive Disorder.

Authors:  Joshua Kaufman; Christine DeLorenzo; Sunia Choudhury; Ramin V Parsey
Journal:  Eur Neuropsychopharmacol       Date:  2016-01-11       Impact factor: 4.600

Review 6.  Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: what depression has in common with impulsive aggression.

Authors:  Charles S Carver; Sheri L Johnson; Jutta Joormann
Journal:  Psychol Bull       Date:  2008-11       Impact factor: 17.737

Review 7.  Dopamine and depression.

Authors:  A S Brown; S Gershon
Journal:  J Neural Transm Gen Sect       Date:  1993

8.  Tyrosine hydroxylase immunoreactivity in the locus coeruleus is elevated in violent suicidal depressive patients.

Authors:  Tomasz Gos; Dieter Krell; Hendrik Bielau; Ralf Brisch; Kurt Trübner; Johann Steiner; Hans-Gert Bernstein; Zbigniew Jankowski; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06-20       Impact factor: 5.270

9.  Focusing on symptoms rather than diagnoses in brain dysfunction: conscious and nonconscious expression in impulsiveness and decision-making.

Authors:  T Palomo; R J Beninger; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2008-08       Impact factor: 3.911

10.  5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology.

Authors:  F K Goodwin; R M Post
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.